Electronics, Healthcare And Water Will Drive Future Success

Key Takeaways

• Strong growth in electronics and healthcare segments, driven by innovation, market demand, and portfolio refocusing, supports higher earnings stability and margin expansion.
  
• Enhanced supply chain agility and resolution of legal liabilities improve cash flow predictability and reduce overall business risk.
  
• Ongoing legal, operational, and geopolitical risks, coupled with portfolio shifts and limited pricing power, threaten DuPont's revenue stability, profitability, and long-term growth prospects.

Catalysts

Provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.

• DuPont's accelerated growth in Electronics, particularly from AI-driven applications, advanced packaging, and high-performance computing, positions the company to capture outsized revenue expansion as node migrations and broader electronics market recovery unfold through 2025 and beyond.
  
• Persistent strength and strategic investment in Healthcare & Water, driven by surging global demand for clean water solutions and healthcare products, leverages favorable demographic, sustainability, and infrastructure trends to drive above-peer organic revenue growth and margin stability.
  
• The company's renewed portfolio focus-post-Qnity spin and recent divestitures in non-core segments-enables greater resource allocation to high-growth specialty businesses, contributing to improved operating margin and increased earnings stability.
  
• DuPont's robust innovation pipeline, including content and share gains in advanced nodes and the water tech portfolio, underpins premium pricing opportunities and sustainably enhances gross margins over the medium to long term.
  
• Improvements in supply chain agility (including local-for-local strategies) and mitigation of major legal liabilities (e.g., structured long-term PFAS settlements) enhance free cash flow predictability and support higher future earnings through reduced volatility and risk.

DuPont de Nemours Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming DuPont de Nemours's revenue will grow by 4.5% annually over the next 3 years.
• Analysts assume that profit margins will increase from 0.6% today to 12.6% in 3 years time.
• Analysts expect earnings to reach $1.8 billion (and earnings per share of $4.41) by about August 2028, up from $71.0 million today.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 25.8x on those 2028 earnings, down from 436.3x today. This future PE is greater than the current PE for the US Chemicals industry at 25.5x.
• Analysts expect the number of shares outstanding to grow by 0.29% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.74%, as per the Simply Wall St company report.

DuPont de Nemours Future Earnings Per Share Growth

Risks

• DuPont continues to face legal liabilities and environmental settlements related to PFAS contamination, with future state-level litigation still pending; while recent settlements are structured to spread cash outflows, ongoing legal risks and potential new cases could negatively affect free cash flow and net earnings over the long term.
  
• The separation of Qnity (ElectronicsCo) and ongoing consideration of further portfolio divestitures (such as the potential sale of Aramids) may result in a smaller, less diversified New DuPont, increasing its operational and financial risk and making future revenue streams and net margins more volatile.
  
• DuPont's electronics segment, especially Qnity, has an outsized exposure to China (30–34% of segment sales), which exposes the company to significant geopolitical, trade, and regulatory risks, including tariffs and evolving US-China technology restrictions, potentially impacting revenue, margin stability, and growth rates.
  
• There is persistent pricing pressure in DuPont's diversified industrials segment, with recent organic sales growth driven mainly by volume recovery and not price increases; this suggests limited pricing power and exposes DuPont to input cost inflation and compressed net margins if raw material costs rise or economic conditions soften.
  
• While DuPont is realigning its portfolio toward high-growth healthcare and water markets, future growth is also dependent on M&A execution and sector trends; any R&D underperformance, failure to acquire or integrate value-enhancing assets, or a slowdown in underlying healthcare or water market fundamentals could result in subdued revenue growth and declining competitiveness.

Valuation

• The analysts have a consensus price target of $88.706 for DuPont de Nemours based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $113.0, and the most bearish reporting a price target of just $47.0.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $14.4 billion, earnings will come to $1.8 billion, and it would be trading on a PE ratio of 25.8x, assuming you use a discount rate of 7.7%.
• Given the current share price of $73.99, the analyst price target of $88.71 is 16.6% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.